Anne-Vibeke Lænkholm

Anne-Vibeke Lænkholm

Clinical Associate Professor


  1. 2022
  2. Published

    Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

    Acs, B. & on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (BIG-NABCG), O. B. O. T. I. K. I. B. C. W. G. O. T. B. I. G. A. N. A. B. C. G. (., 2022, In: Modern Pathology. 35, 10, p. 1362-1369 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Capsulectomy Can Successfully Treat Chronic Encapsulated Breast Seroma: A Case Report

    Fosheim, K., Bojesen, S., Troestrup, H. & Lænkholm, Anne-Vibeke, 2022, In: Cureus. 14, 1, 5 p., e21677.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study

    Hassing, C. M. S., Mejdahl, M. K., Lænkholm, Anne-Vibeke, Kroman, Niels Thorndahl, Knoop, A. S. & Tvedskov, Tove Filtenborg, 2022, In: Breast Cancer Research and Treatment. 196, 1, p. 197-206

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Incorporation of TILs in daily breast cancer care: how much evidence can we bear?

    Lænkholm, Anne-Vibeke, Callagy, G., Balancin, M., Bartlett, J. M. S., Sotiriou, C., Marchio, C., Kok, M., Dos Anjos, C. H. & Salgado, R., 2022, In: Virchows Archiv. 480, 1, p. 147-162 16 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Inter-observer agreement of tumor infiltrating lymphocytes in primary HER2-positive breast cancer and correlation between tissue microarray and full tumor-sections

    Reznitsky, F. M., Jensen, J. D., Knoop, A. & Lænkholm, Anne-Vibeke, 2022, In: APMIS. 130, 9, p. 545-550

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial

    Shenasa, E., Stovgaard, Elisabeth Ida Specht, Jensen, M. B., Asleh, K., Riaz, N., Gao, D., Leung, S., Ejlertsen, Bent Laursen, Lænkholm, Anne-Vibeke & Nielsen, T. O., 2022, In: Cancers. 14, 15, 14 p., 3808.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2021
  9. Published

    The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    El Bairi, K., Haynes, H. R., Blackley, E., Fineberg, S., Shear, J., Turner, S., de Freitas, J. R., Sur, D., Amendola, L. C., Gharib, M., Kallala, A., Arun, I., Azmoudeh-Ardalan, F., Fujimoto, L., Sua, L. F., Liu, S. W., Lien, H. C., Kirtani, P., Balancin, M., El Attar, H. & 31 others, Guleria, P., Yang, W., Shash, E., Chen, I. C., Bautista, V., Do Prado Moura, J. F., Rapoport, B. L., Castaneda, C., Spengler, E., Acosta-Haab, G., Frahm, I., Sanchez, J., Castillo, M., Bouchmaa, N., Md Zin, R. R., Shui, R., Onyuma, T., Yang, W., Husain, Z., Willard-Gallo, K., Coosemans, A., Perez, E. A., Provenzano, E., Choi, H. J., Lænkholm, Anne-Vibeke, Stovgaard, Elisabeth Ida Specht, Nielsen, T., Balslev, E., Sharma, A., Garbyal, Rajendra Singh & The International Immuno-Oncology Biomarker Working Group, T. I. I. B. W. G., 2021, In: npj Breast Cancer. 7, 1, 17 p., 150.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters

    Jørgensen, N., Lænkholm, Anne-Vibeke, Sækmose, S. G., Hansen, Lone Bak & Hviid, Thomas Vauvert F., 2021, In: Clinical Immunology. 232, 12 p., 108847.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer

    Jørgensen, N., Hviid, Thomas Vauvert F., Nielsen, L. B., Sønderstrup, I. M. H., Eriksen, J. O., Ejlertsen, Bent Laursen, Gerdes, Anne-Marie Axø, Kruse, T. A., Thomassen, M., Jensen, M. & Lænkholm, Anne-Vibeke, Aug 2021, In: British Journal of Cancer. 125, p. 1388–1398

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Intra-tumour heterogeneity is one of the main sources of inter-observer variation in scoring stromal tumour infiltrating lymphocytes in triple negative breast cancer

    Kilmartin, D., O’Loughlin, M., Andreu, X., Bagó-Horváth, Z., Bianchi, S., Chmielik, E., Cserni, G., Figueiredo, P., Floris, G., Foschini, M. P., Kovács, A., Heikkilä, P., Kulka, J., Laenkholm, A. V., Liepniece-Karele, I., Marchiò, C., Provenzano, E., Regitnig, P., Reiner, A., Ryška, A. & 8 others, Sapino, A., Stovgaard, E. S., Quinn, C., Zolota, V., Webber, M., Roshan, D., Glynn, S. A. & Callagy, G., 2021, In: Cancers. 13, 17, 4410.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next

ID: 102813499